Avisa Diagnostics Inc. (FOGCF)
FOGCF Stock Price Chart
Explore Avisa Diagnostics Inc. interactive price chart. Choose custom timeframes to analyze FOGCF price movements and trends.
FOGCF Company Profile
Discover essential business fundamentals and corporate details for Avisa Diagnostics Inc. (FOGCF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
17 Feb 2021
Employees
—
Website
https://www.avisadx.comCEO
David S. Joseph
Description
Avisa Diagnostics Inc. operates a clinical-stage medical device company. It is developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates. The company offers clinical proof-of-concept through trials in cystic fibrosis, tuberculosis, and communityacquired pneumonia. It focuses on pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics Inc. is based in Santa Fe, New Mexico.
FOGCF Financial Timeline
Browse a chronological timeline of Avisa Diagnostics Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 21 May 2021
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 18 May 2021
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
FOGCF Stock Performance
Access detailed FOGCF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.